IRMD
IRADIMED CORP
NASDAQ · Healthcare · Medical - Devices · US
$88.41
+9.00%Next report
Analyst consensus
- Next report date
- Feb 9, 2027
- EPS estimate
- $0.59
- Revenue estimate
- $25.4M
Latest reported
- Last report date
- Oct 30, 2026
- EPS actual
- $0.55
- EPS estimate
- $0.55
- Revenue actual
- $24.2M
- Revenue estimate
- $23.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +5.9%
- Revenue beats (12Q)
- 7
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 30, 2026 | $0.55 | $0.55 | In line | $24.2M |
| Jul 31, 2026 | $0.44 | $0.46 | Beat 4.55% | $20.5M |
| May 1, 2026 | $0.45 | $0.49 | Beat 10.11% | $22.0M |
| Aug 1, 2025 | $0.45 | $0.49 | Beat 8.89% | $20.4M |
| Feb 13, 2025 | $0.45 | $0.44 | Miss -2.22% | $19.4M |
| Oct 31, 2024 | $0.39 | $0.43 | Beat 9.41% | $18.3M |
| Aug 1, 2024 | $0.37 | $0.42 | Beat 12.90% | $17.9M |
| May 2, 2024 | $0.34 | $0.36 | Beat 5.57% | $17.6M |
| Feb 8, 2024 | $0.40 | $0.39 | Miss -2.50% | $17.5M |
| Nov 3, 2023 | $0.36 | $0.43 | Beat 19.44% | $16.5M |
| Aug 3, 2023 | $0.31 | $0.36 | Beat 16.13% | $16.1M |
| May 4, 2023 | $0.28 | $0.30 | Beat 7.14% | $15.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 9, 2027